This inventor holds 3 USPTO granted patents and 14 published patent applications and 1 EPO patent. Top assignees: Cullgen (Shanghai), Inc., Vanderbilt University. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2025
Title: Jialiang Wang: Innovator in Biopharmaceuticals
Introduction
Jialiang Wang is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative compounds for medical treatments. With a total of 3 patents, his work focuses on advancing therapeutic options for various diseases.
Latest Patents
One of Jialiang Wang's latest patents involves tropomyosin receptor kinase (TRK) degradation compounds and methods of use. This disclosure relates to bivalent compounds, which are bi-functional small molecule compounds. The compositions comprising these bivalent compounds are designed for the treatment of specific diseases in subjects in need. Additionally, the patent outlines methods for identifying such bivalent compounds, showcasing Wang's commitment to enhancing therapeutic strategies.
Career Highlights
Throughout his career, Jialiang Wang has worked with notable organizations, including Cullgen (Shanghai), Inc. and Vanderbilt University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Jialiang Wang's coworkers include Xiaoran Han and Liqun Chen. Their collaborative efforts have furthered the development of innovative solutions in biopharmaceuticals.
Conclusion
Jialiang Wang's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, benefiting patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
